Eganelisib联合免疫检查点抑制剂和化疗在晚期转移性三阴性乳腺癌中的一线治疗中引发巨噬细胞重编程、免疫激活及肿瘤微环境中细胞外基质重塑
Eganelisib combined with immune checkpoint inhibitor therapy and chemotherapy in frontline metastatic triple-negative breast cancer triggers macrophage reprogramming, immune activation and extracellular matrix reorganization in the tumor microenvironment
DOI 原文链接
用sci-hub下载
如无法下载，请从 Sci-Hub 选择可用站点尝试。
正在获取期刊数据...
发表日期:2024 Aug 30
作者:
DOI:10.1136/jitc-2024-009160
摘要
AI正在翻译并加载中文摘要...